Today@Dal
» Go to news mainCMV Vaccine Study: Participants Needed
Researchers would like to develop a vaccine against CMV. The goal of a CMV vaccine would be to prevent CMV infection so that women would not pass the infection to their fetus. CMV infection of the developing fetus/baby be harmful, including causing hearing loss (deafness) and harming the brain's ability to develop. To date, there is no licensed vaccine against CMV.
Participants needed: Men and women between 18-40 years of age.
If you are interested in participating in this study, please contact Jill:
jill.mutch@iwk.nshealth.ca
470-3860
Recent News
- In Memoriam ‑ Colin Spinney
- Document delivery during Canada Post strike
- New surplus items added in Halifax
- Dal Tigers birthday parties
- Celebrate culture, creativity, and sustainability at the IEW Fashion Show!
- Student Accessibility Closure Friday, November 22
- Where suppliers can meet Dal Procurement
- LSC power outage Saturday, November 23